Samsara BioCapital, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 2 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,451,680
-8.2%
432,0000.0%1.06%
+60.2%
Q2 2023$3,758,400
+166.3%
432,000
-10.0%
0.66%
+126.0%
Q1 2023$1,411,200
-16.0%
480,0000.0%0.29%
-19.3%
Q4 2022$1,680,000
-55.8%
480,0000.0%0.36%
-59.1%
Q3 2022$3,797,000
+0.5%
480,0000.0%0.88%
-12.1%
Q2 2022$3,778,000
-35.2%
480,0000.0%1.01%
-31.4%
Q1 2022$5,832,000
-0.7%
480,0000.0%1.47%
+28.8%
Q4 2021$5,875,000
+25.3%
480,000
+6.7%
1.14%
+54.9%
Q3 2021$4,689,000
+15.9%
450,0000.0%0.74%
+47.5%
Q2 2021$4,046,000
-11.5%
450,0000.0%0.50%
-40.8%
Q1 2021$4,572,000450,0000.84%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders